Related Experiment Video
Updated: Jun 25, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Interaction between fatty pancreas disease and genetically predicted glucose-dependent insulinotropic polypeptide on
Xuechen Wang1, Yucheng Yang1, Shumeng Han1
1Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Translation Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Purpose:
Glucose-dependent insulinotropic polypeptide (GIP) plays a crucial role in lipid metabolism. The effect of GIP on pancreatic lipid and whether it modulates risk of type 2 diabetes (T2D) associated with fatty pancreas remain unknown. The aim of this study was to investigate the interaction between genetically predicted GIP levels and fatty pancreas in the development of T2D.
Methods:
This is a large-scale cohort study using data from the UK Biobank. Participants of White ethnicity without diabetes at the imaging visit were included in the analysis. The loss-of-function GIPR variant E354Q was used for the prediction of fasting GIP levels, and a polygenic risk score (PRS) of postprandial GIP was used for the prediction of postprandial GIP levels. The presence of fatty pancreas disease (FPD) was determined with magnetic resonance imaging (MRI). Diagnosis of T2D was ascertained based on ICD10-CM diagnosis code E11. During a median follow-up of 51 months, 276 cases of incident T2D were identified.
Results:
A significant interaction between the carrying status of E354Q and FPD (p for interaction = 0.018) and between 2hGIP PRS and FPD (p for interaction = 0.015) in the development of T2D was found. FPD is associated with a greater increase of risk of T2D in individuals without E354Q [hazard ratio (HR) 2.44, 95% confidence interval (CI) 1.78-3.34] or with higher levels of genetically predicted postprandial GIP (HR 2.64, 95% CI 1.86-3.76).
Conclusion:
Our findings show that genetically predicted GIP modifies risk of T2D associated with FPD, suggesting that GIP may play a role in linking pancreatic fat accumulation to metabolic dysfunction. These findings are derived from genetically predicted rather than measured GIP.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes I: Introduction
